Molecules/MARGETUXIMAB

MARGETUXIMAB

Molecular Identity

AntibodyApprovedFirst approved 2020

Mechanism of action: Receptor protein-tyrosine kinase erbB-2 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

MargenzaMARGETUXIMABMARGETUXIMAB CMKBMARGETUXIMAB-CMKBMGAH-22MGAH22

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to MARGETUXIMAB

Loading drug network...